Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 24851

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Ganglioside GM4 is a sialic acid-containing glycosphingolipid found primarily in the brain of mammals, particularly in human myelin.1 Ganglioside GM4 is also found on epithelial cells in the intestinal tract of the red sea bream where it is an attachment site for Gram-negative Vibrios, the bacteria that causes vibriosis in humans after ingestion of raw or undercooked seafood.2 Ganglioside GM4 species have been found as 11 out of 61 gangliosides detected in an adrenal neuroblastoma tumor.3 Administration of ganglioside GM4 (80 and 160 µg) prevents development of myelin basic protein-induced experimental autoimmune encephalomyelitis (EAE) in guinea pigs.4 This product contains ganglioside GM4 molecular species with primarily 2-hydroxy C22:0, 2-hydroxy C24:0, and 2-hydroxy C23:0 fatty acyl chain lengths. As this product is derived from a natural source, there may be variations in the sphingoid backbone. [Matreya, LLC. Catalog No. 1535]
WARNING This product is not for human or veterinary use.
1. Gangliosides of human, cat, and rabbit spinal cords and cord myelin. J. Lipid Res. 19(7), 863-871 (1978).
2. Vibrios adhere to epithelial cells in the intestinal tract of red sea bream, Pagrus major, utilizing GM4 as an attachment site. FEMS Microbiol. Lett. 341(1), 18-26 (2013).
3. Mass spectrometry of gangliosides in extracranial tumors: Application to adrenal neuroblastoma. Anal. Biochem. 509, 1-11 (2016).
4. Prevention of experimental allergic encephalomyelitis by ganglioside GM4. Brain Res. 296(1), 174-176 (1984).